Lisa Miller | Director-Investor Relations |
Rick Hawkins | President, Chairman & Chief Executive Officer |
John McKew | Chief Operating Officer & Chief Scientific Officer |
Gene Kennedy | Chief Medical Officer |
Carl Langren | Chief Financial Officer |
Lori Lawley | Senior Vice President, Finance & Corporate Controller |
Charles Duncan | Cantor Fitzgerald |
Lina Kaminski | JonesTrading |
Jacques Villefranc | Stifel |
Good afternoon, ladies and gentlemen, and welcome to Lumos Pharma's First Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this conference call is being recorded. I will now turn the call over to Lisa Miller, Senior Director of Investor Relations.